CXCL8 and cancer: Furthermore, tea inhibits the release of antiinflammatory cytokines such as interleukins (IL-6, IL-8, IL-10, IL-12), as well as the receptor activator of nuclear factor kappa-B ligand (RANKL), and acts as an anticancer agent by stimulating apoptotic processes in cancer cells (Chen et al., 2011).